Navigation Links
PMSI and Ameritox Launch Program to Enhance Quality and Effectiveness of Opioid Therapy
Date:4/14/2010

Creates Unique Urine Drug Testing and Medication Monitoring Service for Workers' Compensation

Tampa, Fla. and Baltimore, Md. (Vocus) April 14, 2010 -- PMSI, one of the nation’s largest providers of specialty products and services for the workers’ compensation market, and Ameritox, the nation’s leader in pain medication monitoring solutions, today announced a strategic partnership to monitor and promote the appropriate use of opioid medications by injured workers.

“The use of opioid analgesics is extremely prevalent in the workers’ compensation population, with nearly 70% of injured workers taking opioids to control pain,” stated Maria Sciame, PharmD, PMSI’s executive director of clinical services. “However, when chronic pain is evident, prescribers frequently order opioids with other related medications which can result in overuse of medications. Additionally, there is potential for fraud and abuse in use of opioids through drug diversion or misuse.”

Historically, it has been difficult to identify which injured workers may be abusing or misusing controlled substances or illicit drugs. The PMSI MedAssessTM Care Management Program, a new drug testing and monitoring service, identifies at-risk individuals and facilitates urine drug testing at the prescriber level.

“The American Pain Society and American Academy of Pain Medicine guidelines recommend using periodic urine drug testing for patients at risk for abuse,” stated Eileen Auen, PMSI’s chief executive officer. “As leaders in the industry, PMSI and Ameritox have worked together to develop a customized program to facilitate this recommended testing. The combination of PMSI’s clinical expertise with Ameritox’s superior urine drug monitoring solutions provides an integrated program unlike any other in the industry.”

“PMSI and Ameritox are providing the workers’ compensation industry with a patient-centered program that helps clinicians maximize patient care while also addressing potential opioid fraud and abuse,” said Ancelmo Lopes, chief executive officer of Ameritox. “By capturing patient medication history, communicating with claims adjusters and case managers, helping physicians to identify appropriate follow-up measures and providing on-going monitoring, we are better able to enhance the quality and cost effectiveness of chronic opioid therapy.”

About PMSI:
PMSI is one of the nation’s largest full-service providers of clinically driven services for Pharmacy, Medical Services and Equipment, and Settlement Solutions and is devoted exclusively to the workers’ compensation and liability markets. For over 34 years, PMSI has led the industry and served as the trusted resource for thousands of insurance payers, state workers’ compensation funds, employers, and third-party administrators. Today, PMSI continues its leadership position by managing millions of pharmacy, medical services and equipment, and settlement transactions each year. For more information, please refer to the PMSI website at www.pmsionline.com.

About Ameritox:
Ameritox is the nation’s leader in pain medication monitoring solutionsSM, offering specialized laboratory testing and reporting services. Ameritox’s expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx GuardianSM, the most thorough and personalized lab service available and the only pain medication monitoring program with a proprietary methodology to help physicians assess whether patients are taking their pain medication as directed. Medication monitoring helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore with laboratory facilities in Midland, Texas and Greensboro, N.C. For more information about pain medication monitoring, please refer to www.ameritox.com.

PMSI Contact:
Shelia Chapman
Executive Director, Marketing
877.ASK.PMSI
shelia.chapman(at)pmsionline(dot)com

Ameritox Contact:
Heather Platisha
Edelman Public Relations
415.486.3227
heather.platisha(at)edelman(dot)com

###

Read the full story at http://www.prweb.com/releases/PMSI/Ameritox/prweb3873084.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MarijuanaDoctors.com Launches the First Online Search and Booking Engine for Patients Seeking Medical Marijuana Doctors
2. ProbioticSmart.com Re-Launches Newly Expanded Online Store for Human, Pet, and Livestock Health Products and Supplements
3. ActiveStrategy iRound™ is Launched to Enable Seamless Capture of Field-Level Performance Management Data
4. AdMonsters Announces the Launch of OPS, to be Held on September 30, 2010 in New York
5. International Fitness Bikini Model Turn Bega-Brand Mogul & Celebrity Jennifer Nicole Lee Launches the JNL iPhone App
6. Upstairs Solutions Teams with PointRight to Launch Industry's First Five-Star Quality Rating System Online Training for Long Term Care Facilities
7. San Diego Cosmetic Dentists Launch New Website and Rejuvenate Online Image
8. WhiteDove Herbals Re-Launches Online Store Rocky Mountain Herbals
9. Dr. Appz Launches Comprehensive Productivity App for iPhone
10. AskDads.com Launches the First Social Networking Site Exclusively for Dads
11. Agency Pioneer SVH Tours & Travel Launches AppleSpecials.com, New Travel Booking Web Site that Showcases First-Hand Videos and Last Minute Specials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PMSI and Ameritox Launch Program to Enhance Quality and Effectiveness of Opioid Therapy
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor ... holds a bachelor degree in religious education and a master degree in theology. , ...
(Date:1/24/2017)... ... 23, 2017 , ... OSF Ventures, the corporate investment arm ... platform headquartered in Silicon Valley that connects startups to corporations and invests in ... three-year agreement to be a corporate sponsor of Plug and Play’s program for ...
(Date:1/24/2017)... ... January 23, 2017 , ... During the ... Carol Francis, Psychologist in the South Bay area , explained “Watching Women’s ... all people and by all people shines as a bright beacon of determination ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... translation and localization services for life science companies, has achieved ISO 17100:2015 ... TÜV SÜD America. ISO 17100 is the globally recognized standard that establishes ...
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters ... management and evaluation leaders with decades of experience who remain current practitioners in ... States healthcare system, there is a renewed demand for versatile, data-driven leadership.The American ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 7D Surgical announced today that ... U.S. Food and Drug Administration (FDA) and a ... North American commercial launch of its innovative Machine-vision ... the 7D Surgical System.  The ... and machine vision algorithms to eliminate the long-standing ...
(Date:1/23/2017)... and Markets has announced the addition of the "Needle Free Drug ... report to their offering. ... Highlights: The report provides a detailed analysis ... Market forecasts till 2025, using estimated market values as the ... Regions and Countries Key developments and strategies observed in ...
(Date:1/23/2017)... Alberta , January 23, 2017 ... del riñón (r enal) y ... sola dosis de a pabetalone    ... hoy los resultados preliminares de un ensayo en fase ... con discapacidad de riñón (renal) severa. Los datos demostraron ...
Breaking Medicine Technology: